Taylor Sandison

Taylor Sandison discloses dealings in Cidara Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 7 February 2010 to 11 September 2024, the count stands at 19 filings.

Market trades split into 2 purchases (€105k) and 5 sales (€62k). On balance, insiders were net buyers of €43k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 11 share grants and 1 option exercise. 2024 to date brings no purchases and 2 sales.

The record was last updated on 13 September 2024 with an open-market sale (€9,765) in Cidara Therapeutics, Inc. The latest purchase dates back some time: it was published 3,441 days ago, on 8 June 2017. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.